Invasive breast carcinoma - IARC

2180. Park JS, Jones RW, McLean MR,
Currie JL, Woodruff JD, Shah KV, Kurman
RJ (1991). Possible etiologic heterogeneity
of vulvar intraepithelial neoplasia. A correlation
of pathologic characteristics with
human papillomavirus detection by in situ
hybridization and polymerase chain reaction.
Cancer 67: 1599-1607.
2181. Park SH, Kim I (1994). Histogenetic
consideration of ovarian sex cord-stromal
tumors analyzed by expression pattern of
cytokeratins, vimentin, and laminin.
Correlation studies with human gonads.
Pathol Res Pract 190: 449-456.
2182. Park SK, Yoo KY, Lee SJ, Kim SU, Ahn
SH, Noh DY, Choe KJ, Strickland PT,
Hirvonen A, Kang D (2000). Alcohol consumption,
glutathione S-transferase M1
and T1 genetic polymorphisms and breast
cancer risk. Pharmacogenetics 10: 301-
309.
2183. Park SY, Kim HS, Hong EK, Kim WH
(2002). Expression of cytokeratins 7 and 20
in primary carcinomas of the stomach and
colorectum and their value in the differential
diagnosis of metastatic carcinomas to
the ovary. Hum Pathol 33: 1078-1085.
2184. Park TW, Richart RM, Sun XW,
Wright TC Jr. (1996). Association between
human papillomavirus type and clonal status
of cervical squamous intraepithelial
lesions. J Natl Cancer Inst 88: 355-358.
2185 . Parkash V, Carcangiu ML (1995).
Transformation of ovarian dysgerminoma
to yolk sac tumor: evidence for a histogenetic
continuum. Mod Pathol 8: 881-887.
2186. Parker RG, Grimm P, Enstrom JE
(1989). Contralateral breast cancers following
treatment for initial breast cancers
in women. Am J Clin Oncol 12: 213-216.
2187. Parker WH, Fu YS, Berek JS (1994).
Uterine sarcoma in patients operated on
for presumed leiomyoma and rapidly growing
leiomyoma. Obstet Gynecol 83: 414-418.
2188. Parkin DM, Bray F, Ferlay J, Pisani P
(2001). Estimating the world cancer burden:
Globocan 2000. Int J Cancer 94: 153-
156.
2189. Parkin DM, Whelan SL, Ferlay J,
Raymond L, Young J (1997). C a n c e r
Incidence in Five Continents, Vol. VII (IARC
Scientific Publication N°143). International
Agency for Research on Cancer:
Lyon, France.
2190. Parl FF, Richardson LD (1983). The
histologic and biologic spectrum of tubular
carcinoma of the breast. Hum Pathol 14:
694-698.
2191. Patchefsky AS, Frauenhoffer CM,
Krall RA, Cooper HS (1979). Low-grade
mucoepidermoid carcinoma of the breast.
Arch Pathol Lab Med 103: 196-198.
2192. Patchefsky AS, Shaber GS, Schwartz
GF, Feig SA, Nerlinger RE (1977). The
pathology of breast cancer detected by
mass population screening. Cancer 40 :
1659-1670.
2193. Patel KJ, Yu VP, Lee H, Corcoran A,
Thistlethwaite FC, Evans MJ, Colledge WH,
Friedman LS, Ponder BA, Venkitaraman AR
(1998). Involvement of Brca2 in DNA repair.
Mol Cell 1: 347-357.
2194. Paterakos M, Watkin WG, Edgerton
SM, Moore DH, Thor AD (1999). Invasive
micropapillary carcinoma of the breast: a
prognostic study. Hum Pathol 30: 1459-
1463.
2195. Patey DH, Scarff RW (1928). The position
of histology in the prognosis of carcinoma
of the breast. Lancet 1: 801-804.
2196. Patsner B (2001). Primary endodermal
sinus tumor of the endometrium presenting
as "recurrent" endometrial adenocarcinoma.
Gynecol Oncol 80: 93-95.
2197. Pattillo RA, Sasaki S, Katayama KP,
Roesler M, Mattingly RF (1981). Genesis of
46,XY hydatidiform mole. Am J Obstet
Gynecol 141: 104-105.
2198. Paull TT, Cortez D, Bowers B, Elledge
SJ, Gellert M (2001). From the Cover: Direct
DNA binding by Brca1. Proc Natl Acad Sci
USA 98: 6086-6091.
2199. Paulus DD (1990). Lymphoma of the
breast. Radiol Clin North Am 28: 833-840.
2200. Pautier P, Genestie C, Rey A, Morice
P, Roche B, Lhomme C, Haie-Meder C,
Duvillard P (2000). Analysis of clinicopathologic
prognostic factors for 157 uterine
sarcomas and evaluation of a grading
score validated for soft tissue sarcoma.
Cancer 88: 1425-1431.
2201. Pedersen L, Holck S, Schiodt T,
Zedeler K, Mouridsen HT (1994). Medullary
carcinoma of the breast, prognostic importance
of characteristic histopathological
features evaluated in a multivariate Cox
analysis. Eur J Cancer 30A: 1792-1797.
2202. Pedersen L, Larsen JK, Christensen
IJ, Lykkesfeldt A, Holck S, Schiodt T (1994).
DNA ploidy and S-phase fraction in
medullary carcinoma of the breast--a flow
cytometric analysis using archival material.
Breast Cancer Res Treat 29: 297-306.
2203. Pedersen L, Zedeler K, Holck S,
Schiodt T, Mouridsen HT (1991). Medullary
carcinoma of the breast, proposal for a
new simplified histopathological definition.
Based on prognostic observations and
observations on inter- and intraobserver
variability of 11 histopathological characteristics
in 131 breast carcinomas with
medullary features. Br J Cancer 63: 591-
595.
2204. Pedersen L, Zedeler K, Holck S,
Schiodt T, Mouridsen HT (1995). Medullary
carcinoma of the breast. Prevalence and
prognostic importance of classical risk
factors in breast cancer. Eur J Cancer 31A:
2289-2295.
2204a. Pedeutour F, Ligon AH, Morton CC
(1999). [Genetics of uterine leiomyomata].
Bull Cancer 86: 920-928.
2205. Peiro G, Bornstein BA, Connolly JL,
Gelman R, Hetelekidis S, Nixon AJ, Recht
A, Silver B, Harris JR, Schnitt SJ (2000).
The influence of infiltrating lobular carcinoma
on the outcome of patients treated
with breast-conserving surgery and radia -
tion therapy. Breast Cancer Res Treat 59:
49-54.
2206. Peiro G, Diebold J, Lohse P,
Ruebsamen H, Lohse P, Baretton GB, Lohrs
U (2002). Microsatellite instability, loss of
heterozygosity, and loss of hMLH1 and
hMSH2 protein expression in endometrial
carcinoma. Hum Pathol 33: 347-354.
2207. Pejovic T, Burki N, Odunsi K, Fiedler
P, Achong N, Schwartz PE, Ward DC
(1999). Well-differentiated mucinous carcinoma
of the ovary and a coexisting
Brenner tumor both exhibit amplification of
12q14-21 by comparative genomic
hybridization. Gynecol Oncol 74: 134-137.
2208. Pejovic T, Heim S, Alm P, Iosif S,
Himmelmann A, Skjaerris J, Mitelman F
(1993). Isochromosome 1q as the sole karyotypic
abnormality in a Sertoli cell tumor of
the ovary. Cancer Genet Cytogenet 65: 79-
80.
2209. Pejovic T, Heim S, Mandahl N,
Elmfors B, Floderus UM, Furgyik S, Helm G,
Willen H, Mitelman F (1990). Trisomy 12 is a
consistent chromosomal aberration in
benign ovarian tumors. G e n e s
Chromosomes Cancer 2: 48-52.
2210. Pekin T, Eren F, Pekin O (2000).
Leiomyosarcoma of the broad ligament:
case report and literature review. Eur J
Gynaecol Oncol 21: 318-319.
2211. Pelkey TJ, Frierson HF Jr., Mills SE,
Stoler MH (1998). The diagnostic utility of
inhibin staining in ovarian neoplasms. Int J
Gynecol Pathol 17: 97-105.
2212. Pelosi G, Martignoni G, Bonetti F
(1991). Intraductal carcinoma of mammarytype
apocrine epithelium arising within a
papillary hydradenoma of the vulva. Report
of a case and review of the literature.
Arch Pathol Lab Med 115: 1249-1254.
2213. Peltomaki P, Aaltonen LA, Sistonen P,
Pylkkanen L, Mecklin JP, Jarvinen H,
Green JS, Jass JR, Weber JL, Leach FS,
Petersen GM, Hamilton SR, de la Chapelle
A, Vogelstein B. (1993). Genetic mapping of
a locus predisposing to human colorectal
cancer. Science 260: 810-812.
2214. Peltomaki P, Vasen HF (1997).
Mutations predisposing to hereditary nonpolyposis
colorectal cancer: database and
results of a collaborative study. The
International Collaborative Group on
Hereditary Nonpolyposis Colorectal
Cancer. Gastroenterology 113: 1146-1158.
2214a. Penrose LS, Mackenzie JH, Karn
MN (1948). A genetical study of human
mammary cancer. Ann Euegenics 14: 234-
266.
2215. Pensler JM, Silverman BL, Sanghavi
J, Goolsby C, Speck G, Brizio-Molteni L,
Molteni A (2000). Estrogen and progesterone
receptors in gynecomastia. Plast
Reconstr Surg 106: 1011-1013.
2216. Pereira H, Pinder SE, Sibbering DM,
Galea MH, Elston CW, Blamey RW,
Robertson JF, Ellis IO (1995). Pathological
prognostic factors in breast cancer. IV:
Should you be a typer or a grader? A com -
parative study of two histological prognostic
features in operable breast carcinoma.
Histopathology 27: 219-226.
2217. Perez CA, Arneson AN, Dehner LP,
Galakatos A (1974). Radiation therapy in
carcinoma of the vagina. Obstet Gynecol
44: 862-872.
2218. Perou CM, Sorlie T, Eisen MB, van de
Rijn M, Jeffrey SS, Rees CA, Pollack JR,
Ross DT, Johnsen H, Akslen LA, Fluge O,
Pergamenschikov A, Williams C, Zhu SX,
Lonning PE, Borresen-Dale AL, Brown PO,
Botstein D (2000). Molecular portraits of
human breast tumours. Nature 406: 747-
752.
2219. Perrin L, Ward B (1995). Small cell
carcinoma of the cervix. Int J Gynecol
Cancer 5: 200-203.
2 2 2 0 . Persaud V, Anderson MF (1977).
Endometrial stromal sarcoma of the broad
ligament arising in an area of endometriosis
in a paramesonephric cyst. Case
report. Br J Obstet Gynaecol 84: 149-152.
2221. Persons DL, Hartmann LC, Herath JF,
Keeney GL, Jenkins RB (1994).
Fluorescence in situ hybridization analysis
of trisomy 12 in ovarian tumors. Am J Clin
Pathol 102: 775-779.
2222. Perzin KH, Lattes R (1972). Papillary
adenoma of the nipple (florid papillomatosis,
adenoma, adenomatosis). A clinicopathologic
study. Cancer 29: 996-1009.
2223. Peters GN, Wolff M (1983). Adenoid
cystic carcinoma of the breast. Report of
11 new cases: review of the literature and
discussion of biological behavior. Cancer
52: 680-686.
2224. Peters GN, Wolff M, Haagensen CD
(1981). Tubular carcinoma of the breast.
Clinical pathologic correlations based on
100 cases. Ann Surg 193: 138-149.
2225. Peters WA, III, Andersen WA,
Hopkins MP, Kumar NB, Morley GW (1988).
Prognostic features of carcinoma of the
fallopian tube. Obstet Gynecol 71: 757-762.
2226. Peters WA, III, Kumar NB, Andersen
WA, Morley GW (1985). Primary sarcoma
of the adult vagina: a clinicopathologic
study. Obstet Gynecol 65: 699-704.
2227. Peters WA, III, Kumar NB, Morley
GW (1985). Carcinoma of the vagina.
Factors influencing treatment outcome.
Cancer 55: 892-897.
2228. Peters WM, Wells M, Bryce FC
(1984). Mullerian clear cell carcinofibroma
of the uterine corpus. Histopathology 8:
1069-1078.
2229. Peterse JL (1993). Breast carcinoma
with an unexpected inside out growth pattern,
rotation of polarisation associated
with angioinvasion. Pathol Res Pract 189:
780.
2230. Peto J, Collins N, Barfoot R, Seal S,
Warren W, Rahman N, Easton DF, Evans C,
Deacon J, Stratton MR (1999). Prevalence
of BRCA1 and BRCA2 gene mutations in
patients with early-onset breast cancer. J
Natl Cancer Inst 91: 943-949.
2231. Petridou E, Giokas G, Kuper H, Mucci
LA, Trichopoulos D (2000). Endocrine correlates
of male breast cancer risk: a casecontrol
study in Athens, Greece. Br J
Cancer 83: 1234-1237.
2232. Petru E, Pickel H, Heydarfadai M,
Lahousen M, Haas J, Schaider H,
Tamussino K (1992). Nongenital cancers
metastatic to the ovary. Gynecol Oncol 44:
83-86.
2233. Petterson F (1991). Annual Report of
the Treatment in Gynecological Cancer.
International Federation of Gynecology
and Obstetrics: Stockholm.
2234. Pettinato G, Insabato L, De Chiara A,
Manco A, Petrella G (1989). High-grade
mucoepidermoid carcinoma of the breast.
Fine needle aspiration cytology and clinicopathologic
study of a case. Acta Cytol
33: 195-200.
2235. Pettinato G, Manivel JC, Insabato L,
De Chiara A, Petrella G (1988). Plasma cell
granuloma (inflammatory pseudotumor) of
the breast. Am J Clin Pathol 90: 627-632.
2236. Pharoah PD, Antoniou A, Bobrow M,
Zimmern RL, Easton DF, Ponder BA (2002).
Polygenic susceptibility to breast cancer
and implications for prevention. Nat Genet
31: 33-36.
2237. Pharoah PD, Day NE, Caldas C (1999).
Somatic mutations in the p53 gene and
prognosis in breast cancer: a meta-analysis.
Br J Cancer 80: 1968-1973.
2238. Pharoah PD, Day NE, Duffy S, Easton
DF, Ponder BA (1997). Family history and
the risk of breast cancer: a systematic
review and meta-analysis. Int J Cancer 71:
800-809.
2239. Pharoah PD, Easton DF, Stockton DL,
Gayther S, Ponder BA (1999). Survival in
familial, BRCA1-associated, and BRCA2-
associated epithelial ovarian cancer.
United Kingdom Coordinating Committee
for Cancer Research (UKCCCR) Familial
Ovarian Cancer Study Group. Cancer Res
59: 868-871.
References 407